Skip to content
lifestyle.harcourthealth.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Zenas BioPharma
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2026
Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
February 11, 2026
Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
←
Previous Page
1
2